Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001140361-24-049412
Filing Date
2024-12-13
Accepted
2024-12-13 16:06:53
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-3 ny20039376x2_s3.htm S-3 615417
2 EXHIBIT 1.2 ny20039376x2_ex1-2.htm EX-1.2 257232
3 EXHIBIT 4.2 ny20039376x2_ex4-2.htm EX-4.2 268030
4 EXHIBIT 5.1 ny20039376x2_ex5-1.htm EX-5.1 26990
5 EXHIBIT 5.2 ny20039376x2_ex5-2.htm EX-5.2 7899
6 EXHIBIT 23.3 ny20039376x2_ex23-3.htm EX-23.3 2265
7 EXHIBIT 23.4 ny20039376x2_ex23-4.htm EX-23.4 2184
8 FILING FEES TABLE ny20039376x2_ex107.htm EX-FILING FEES 107036
9 logo_cartesian.jpg GRAPHIC 42894
10 logo_cartesianx1.jpg GRAPHIC 58064
11 ny20039376x2_ex5-1logo01.jpg GRAPHIC 7456
  Complete submission text file 0001140361-24-049412.txt   1437272
Mailing Address 7495 NEW HORIZON WAY FREDERICK MD 21703
Business Address 7495 NEW HORIZON WAY FREDERICK MD 21703 301-348-8698
Cartesian Therapeutics, Inc. (Filer) CIK: 0001453687 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-283803 | Film No.: 241548389
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)